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Letter to the Editor
Prevalence and risk factors for human immunodeficiency 
virus infection in pregnant women in Eastern Ghana 
Dear Editor,
Determining HIV incidence is a useful tool for improving the 
targeting of populations for interventions and assessing the 
effectiveness of prevention strategies. A reduction in perinatal 
transmission of HIV is dependent on women seeking prenatal 
care, having access to an HIV test, agreeing to interventions 
such as antiretroviral therapy, and considering alternatives to 
breastfeeding. Thus, the aim of this study was to determine the 
seroprevalence and risk factors for human immunodeficiency 
virus (HIV) positivity among pregnant women in Eastern 
Ghana. 
Between December 2008 and March 2009, a total of 1,500 
apparently healthy pregnant women who visited three hospitals 
in Eastern Ghana – Asesewa Government Hospital (AGH) in 
Upper Manya Krobo district, Holy Family Hospital (HFH) 
in Kwahu West district, and Somanya Polyclinic (SPC) in Yilo 
Krobo district – were consecutively recruited for this study after 
obtaining their informed consent. At every visit a standardized 
questionnaire was interview-administered to obtain data on 
socio-demographics, reproductive history, job status, social 
support, mental health, and health care utilizations. HIV, 
hepatitis B surface antigen (HBsAg), hemoglobin and sickling 
tests were done as a prenatal check-up. Univariate and 
multivariate odds ratios (OR), both with 95% confidence interval 
(CI), were calculated. 
A total of 1,109 apparently healthy pregnant women with 
a mean age of 26.85 ± 6.71 years were screened. Overall 
HIV positive rate was 8.0%. The risk factors associated with 
acquisition of HIV-1 in univariate analyses were older age, 
HBsAg positive status, and substantial alcohol use. These 
factors were analyzed in multiple logistic regression analysis. 
Age groups 25-29 (OR 2.770; 95% CI; 1.023-7.499) and > 35 (OR 
3.141; 95% CI; 1.131-8.723), and HBsAg positive status (OR 2.376; 
95% CI; 1.261-4.476) remained significantly associated with 
acquisition of HIV (Table 1). 
HIV prevalence among young pregnant women (15-24 
years) is used as a proxy for measuring the rate of new 
infections in a population.1 In contrast, in this study, women 
aged 25-29 years were 2.77 times more likely to be infected 
than women of < 20 age. This suggests that women who 
are at the peak of their reproductive years are more prone 
to HIV infection. Due to shared routes of transmission, 
 n HIV positivity (%) Adusted OR 95% CI
Age
 < 20 169 4.7 1
 20-24 267 6.7 1.891 0.669 5.346
 25-29 287 9.1 2.770 1.023 7.499
 30-34 183 8.2 2.077 0.709 6.082
 35+ 194 10.8 3.141 1.131 8.723
Alcohol
 No 1,011 7.4 1
 Yes 96 14.6 1.833 0.928 3.619
HBsAg
 Negative 873 7.0 1
 Positive 95 14.7 2.376 1.261 4.476
Table 1 - Multiple logistic regression analysis for human immunodeficiency virus (HIV) positivity in pregnant women in 
Eastern region of Ghana (2008-2009)
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a frequent occurrence of HIV/hepatitis co-infections seems 
likely. In countries with high hepatitis B virus (HBV) 
endemicity such as Ghana (> 8% affected)2, the principal 
routes of HBV transmission are perinatal or in early 
childhood; thus, HBV infection usually precedes HIV infection 
by decades. In these countries, the majority of studies show 
HBV coinfection prevalence of 10-20%.3 This study found 
14.7% HIV seropositivity prevalence rate among the HBsAg 
positive pregnant women. HIV infection negatively impacts 
all phases of the natural course of hepatitis B. The goals of 
HIV treatment during pregnancy are to optimize the mother’s 
health and to minimize the risk of vertical transmission. 
Therefore, determining the HIV status of pregnant women 
is a key factor to the success of any prevention program. 
Especially, focusing on the patients with high risk can save 
money in resource-limited countries. Facilities for early 
infant diagnosis using molecular techniques will help in the 
identification of infected children for support. As always, 
prevention is better than cure.
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